| 0 (0%) | 02-21 18:47 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 20.89 | 1-year : | 22.58 |
| Resists | First : | 17.89 | Second : | 19.34 |
| Pivot price | 17  |
|||
| Supports | First : | 15.55 | Second : | 12.93 |
| MAs | MA(5) : | 16.87 |
MA(20) : | 17.39 |
| MA(100) : | 17.38 |
MA(250) : | 14.81 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 44.9 |
D(3) : | 40 |
| RSI | RSI(14): 45.4 |
|||
| 52-week | High : | 21.5 | Low : | 9.6 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MESO ] has closed above bottom band by 44.5%. Bollinger Bands are 30.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 16.99 - 17.1 | 17.1 - 17.2 |
| Low: | 16.47 - 16.59 | 16.59 - 16.68 |
| Close: | 16.72 - 16.9 | 16.9 - 17.05 |
Sat, 21 Feb 2026
Mesoblast (MESO) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Fri, 20 Feb 2026
How to watch Mesoblast half-year 2025 results webcast live - Stock Titan
Fri, 20 Feb 2026
(MESO) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Wed, 18 Feb 2026
Town sells land to out-of-state biomedical company for new facility - The Business Journals
Wed, 11 Feb 2026
Mesoblast: Real-World Data Validates The Bull Case For Ryoncil (NASDAQ:MESO) - Seeking Alpha
Fri, 09 Jan 2026
Whole-brain meso-vein imaging in living humans using fast 7-T MRI - Science | AAAS
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 129 (M) |
| Shares Float | 853 (M) |
| Held by Insiders | 5 (%) |
| Held by Institutions | 3 (%) |
| Shares Short | 2,640 (K) |
| Shares Short P.Month | 2,490 (K) |
| EPS | -0.99 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.46 |
| Profit Margin | 0 % |
| Operating Margin | -302.4 % |
| Return on Assets (ttm) | -5.4 % |
| Return on Equity (ttm) | -19 % |
| Qtrly Rev. Growth | 458.6 % |
| Gross Profit (p.s.) | -0.18 |
| Sales Per Share | 0.13 |
| EBITDA (p.s.) | -0.46 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -50 (M) |
| Levered Free Cash Flow | -55 (M) |
| PE Ratio | -17.23 |
| PEG Ratio | 0 |
| Price to Book value | 35.91 |
| Price to Sales | 126.62 |
| Price to Cash Flow | -43.61 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|